ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.
Domain
artbio.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$132.0M
Founded
2020
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does ARTBIO use?+
ARTBIO uses 8 technologies including Gatsby, GSAP, React.
What industry is ARTBIO in?+
ARTBIO operates in the Biotechnology industry.
Where is ARTBIO based?+
ARTBIO is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026